EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma Proteomics of Diabetic Kidney Disease Among Asians With Younger-Onset Type 2 Diabetes

Resham Lal Gurung iD, Huili Zheng, Hiromi Wai Ling Koh, Yiamunaa M, Jian-Jun Liu, Sylvia Liu, Clara Chan, Keven Ang, Clara Si Hua Tan, Radoslaw Mikolaj Sobota, Tavintharan Subramaniam, Chee Fang Sum und 1 weitere

The Journal of Clinical Endocrinology & Metabolism · 21.01.2025 · 110 (2) · e239-e248

DOI: 10.1210/clinem/dgae266 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 16.04.2024. Verfasst von Resham Lal Gurung und 12 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Unit, Khoo Teck Puat Hospital, Singapore 768828. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Nephropathies, Biomarkers, Blood Proteins. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by the Alexandra Health Fund, Singapore National Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Patients with younger onset of type 2 diabetes (YT2D) have increased risk for kidney failure compared to those with late onset. However, the mechanism of diabetic kidney disease (DKD) progression in this high-risk group is poorly understood.

Objective

This work aimed to identify novel biomarkers and potential causal proteins associated with DKD progression in patients with YT2D.

Methods

Among YT2D (T2D onset age <40 years), 144 DKD progressors (cases) were matched for T2D onset age, sex, and ethnicity with 292 nonprogressors (controls) and divided into discovery and validation sets. DKD progression was defined as decline of estimated glomerular filtration rate (eGFR) of 3 mL/min/1.73 m2 or greater or 40% decline in eGFR from baseline. A total of 1472 plasma proteins were measured through a multiplex immunoassay that uses a proximity extension assay technology. Multivariable logistic regression was used to identify proteins associated with DKD progression. Mendelian randomization (MR) was used to evaluate causal relationship between plasma proteins and DKD progression.

Results

Forty-two plasma proteins were associated with DKD progression, independent of traditional cardiorenal risk factors, baseline eGFR, and urine albumin-to-creatinine ratio. The proteins identified were related to inflammatory and remodeling biological processes. Our findings suggest angiogenin as one of the top signals (odds ratio = 5.29; 95% CI, 2.39-11.73; P = 4.03 × 10−5). Furthermore, genetically determined plasma angiogenin level was associated with increased odds of DKD progression.

Conclusion

Large-scale proteomic analysis identified novel proteomic biomarkers for DKD progression in YT2D. Genetic evidence suggest a causal role of plasma angiogenin in DKD progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Diabetic NephropathiesBiomarkersBlood ProteinsHumansMaleFemaleAdultAge of OnsetProteomicsDisease ProgressionAsian PeopleGlomerular Filtration RateCase-Control StudiesMiddle AgedRisk FactorsMendelian Randomization Analysis

Stichwörter der Autor:innen

diabetes kidney diseaseproteomicsyounger onset of type 2 diabetes

Substanzen

BiomarkersBlood Proteins

Autor:innen und Institutionen

  • Clinical Research Unit, Khoo Teck Puat Hospital, Singapore 768828.
  • Cardiovascular and Metabolic Disorders Signature Research Program, Duke-NUS Medical School, Singapore 169857.
  • Institute of Molecular and Cell Biology, Singapore 138673.
  • Diabetes Centre, Admiralty Medical Centre, Singapore 730676.
  • Saw Swee Hock School of Public Heath, Singapore 117549.
  • Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232.

ORCID-Profile: Resham Lal Gurung, Su Chi Lim

Förderung

  • This work was supported by the Alexandra Health Fund
  • Singapore National Medical Research Council

Zitieren

APA

Gurung, R. L., Zheng, H., Koh, H. W. L., M, Y., Liu, J. J., Liu, S., Chan, C., Ang, K., Tan, C. S. H., Sobota, R. M., Subramaniam, T., Sum, C. F., & Lim, S. C. (2025). Plasma Proteomics of Diabetic Kidney Disease Among Asians With Younger-Onset Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism, 110(2), e239-e248. https://doi.org/10.1210/clinem/dgae266

Vancouver

Gurung RL, Zheng H, Koh HWL, M Y, Liu JJ, Liu S, et al. Plasma Proteomics of Diabetic Kidney Disease Among Asians With Younger-Onset Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 2025;110(2):e239-e248. doi:10.1210/clinem/dgae266

BibTeX
@article{Gurung2025,
  author = {Gurung, Resham Lal and Zheng, Huili and Koh, Hiromi Wai Ling and M, Yiamunaa and Liu, Jian-Jun and Liu, Sylvia and Chan, Clara and Ang, Keven and Tan, Clara Si Hua and Sobota, Radoslaw Mikolaj and Subramaniam, Tavintharan and Sum, Chee Fang and Lim, Su Chi},
  title = {Plasma Proteomics of Diabetic Kidney Disease Among Asians With Younger-Onset Type 2 Diabetes},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {2},
  pages = {e239--e248},
  doi = {10.1210/clinem/dgae266}
}
Kostenlos starten →